OverviewRetatrutide is a investigational triple-agonist peptide used in metabolic research to examine activity across GLP-1, GIP, and glucagon receptor pathways. Research FocusLaboratory use focuses on multi-agonist receptor models, signaling integration, and incretin-related biochemical processes. Mechanism of InterestIts triple-agonist profile supports research into receptor crosstalk, intracellular signal transduction, and metabolic pathway mapping. Compliance NoticeFor research only. Not for human consumption.